CA2812132C - Natural igm antibodies and inhibitors thereof - Google Patents

Natural igm antibodies and inhibitors thereof Download PDF

Info

Publication number
CA2812132C
CA2812132C CA2812132A CA2812132A CA2812132C CA 2812132 C CA2812132 C CA 2812132C CA 2812132 A CA2812132 A CA 2812132A CA 2812132 A CA2812132 A CA 2812132A CA 2812132 C CA2812132 C CA 2812132C
Authority
CA
Canada
Prior art keywords
glu
leu
lys
ala
gin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2812132A
Other languages
English (en)
French (fr)
Other versions
CA2812132A1 (en
Inventor
Michael C. Carroll
Francis D. Moore, Jr.
Herbert B. Hechtman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard College
Brigham and Womens Hospital Inc
Childrens Medical Center Corp
Original Assignee
Harvard College
Brigham and Womens Hospital Inc
Childrens Medical Center Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College, Brigham and Womens Hospital Inc, Childrens Medical Center Corp filed Critical Harvard College
Priority claimed from CA002560066A external-priority patent/CA2560066A1/en
Publication of CA2812132A1 publication Critical patent/CA2812132A1/en
Application granted granted Critical
Publication of CA2812132C publication Critical patent/CA2812132C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Peptides Or Proteins (AREA)
CA2812132A 2004-03-01 2005-03-01 Natural igm antibodies and inhibitors thereof Expired - Fee Related CA2812132C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US54912304P 2004-03-01 2004-03-01
US60/549,123 2004-03-01
US58864804P 2004-07-16 2004-07-16
US60/588,648 2004-07-16
CA002560066A CA2560066A1 (en) 2004-03-01 2005-03-01 Natural igm antibodies and inhibitors thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002560066A Division CA2560066A1 (en) 2004-03-01 2005-03-01 Natural igm antibodies and inhibitors thereof

Publications (2)

Publication Number Publication Date
CA2812132A1 CA2812132A1 (en) 2005-09-15
CA2812132C true CA2812132C (en) 2016-08-09

Family

ID=38126323

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2812132A Expired - Fee Related CA2812132C (en) 2004-03-01 2005-03-01 Natural igm antibodies and inhibitors thereof

Country Status (3)

Country Link
CN (1) CN1977043B (zh)
CA (1) CA2812132C (zh)
ES (1) ES2360964T3 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011261270A1 (en) * 2010-06-03 2012-12-13 Abraxis Bioscience, Llc Peripheral blood SPARC antibodies and uses thereof

Also Published As

Publication number Publication date
CN1977043A (zh) 2007-06-06
CN1977043B (zh) 2012-07-04
CA2812132A1 (en) 2005-09-15
ES2360964T3 (es) 2011-06-10

Similar Documents

Publication Publication Date Title
US9914751B2 (en) Natural IGM antibodies and inhibitors thereof
US7875259B2 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
KR20060120161A (ko) 항체
US20100136684A1 (en) Natural IgM Antibodies
CA2812132C (en) Natural igm antibodies and inhibitors thereof
US20040131607A1 (en) Methods and compositions for inhibiting immunoglobulin-mediated reperfusion injury
US20240024520A1 (en) Autonomous knob domain peptides
AU2012200909B2 (en) Natural lgM antibodies and inhibitors thereof
KR20220048028A (ko) 항-cd19 항체 및 그의 용도
EP1286682B1 (en) Methods and compositions for inhibiting immunoglobulin-mediated-reperfusion injury
WO2024153146A1 (zh) 抗nmda受体自身免疫性脑炎新型抗体及其用途
AU2016202118A1 (en) Carrier immunoglobulins and uses thereof
KR20230098335A (ko) 클리핑 비율이 감소된 항원 결합 도메인

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20130404

MKLA Lapsed

Effective date: 20200302